Enhanced Diabetes Research with Vascularized Stem Cell Islet Organoids
Scientists have developed vascularized stem cell-derived pancreatic organoids that better mimic the natural environment of the pancreas, enhancing diabetes research and therapy development.
Researchers led by Maike Sander at the Max Delbrück Center have made significant progress in diabetes modeling by creating vascularized organoids derived from human pluripotent stem cells. These specially engineered organoids replicate the pancreatic islet environment more accurately by incorporating functional blood vessel networks. Published in Developmental Cell, this breakthrough offers a promising platform for studying pancreatic function and developing therapies.
The team successfully integrated human endothelial cells, which form blood vessels, and fibroblasts into the stem cell-derived pancreatic islet clusters. Through extensive experimentation over five years, they optimized cell culture conditions to promote survival, growth, and maturation of the organoids, resulting in a network of blood vessel-like structures that penetrate the islets.
Compared to non-vascularized organoids, the vascularized versions demonstrated higher insulin secretion, especially under high-glucose conditions, indicating enhanced maturation of beta cells. Mechanistically, the blood vessel cells aid in creating the extracellular matrix and secrete growth factors like BMP, which further promote beta cell development.
The team also incorporated microfluidic systems to simulate blood flow, which further increased cell maturity and function. Importantly, these vascularized organoids proved effective in vivo; when transplanted into diabetic mice, they significantly improved insulin secretion and disease outcomes compared to non-vascularized models.
Looking ahead, Sander’s team aims to use these vascularized organoids to study type 1 diabetes, focusing on immune cell interactions that lead to beta cell destruction. By growing patient-derived organoids and combining them with immune cells on microfluidic chips, the research could unlock new insights into autoimmune processes and pave the way for improved treatments.
This advancement marks a crucial step in creating highly realistic models of pancreatic function, offering valuable tools for understanding diabetes and developing regenerative therapies.
Source: https://medicalxpress.com/news/2025-05-vascularized-stem-cell-islet-organoids.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Emerging Research Links Emulsifiers to Potential Health Risks
Emerging scientific research indicates that common emulsifiers in processed foods may disrupt gut health, potentially leading to inflammation and chronic diseases. Learn more about the latest findings and health implications.
Revolutionizing Cancer Treatment with Optical Fiber Technology
Optical fiber technology is revolutionizing cancer treatment by enabling real-time monitoring and precise delivery of radiation therapy, improving outcomes and reducing side effects. Discover how these tiny fibers are transforming oncology care.
Innovative Toolkit Developed by Researchers to Combat Brain Disorders
Discover how researchers from UC Irvine have developed advanced AAV vector tools to target specific brain cells, opening new pathways for treating neurological disorders like Alzheimer's and stroke.
Breakthrough in Breast Cancer Treatment: Dimeric VIPR2 as a Promising Target
Hiroshima University researchers identify VIPR2 receptor dimerization as a key factor in breast cancer progression, paving the way for targeted therapies that inhibit tumor growth and metastasis.